Buck Wealth Strategies LLC Has $6.45 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Buck Wealth Strategies LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 14.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 12,251 shares of the healthcare conglomerate’s stock after purchasing an additional 1,527 shares during the quarter. UnitedHealth Group makes up 2.4% of Buck Wealth Strategies LLC’s holdings, making the stock its 26th biggest holding. Buck Wealth Strategies LLC’s holdings in UnitedHealth Group were worth $6,451,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the business. Axiom Financial Strategies LLC bought a new position in UnitedHealth Group during the 1st quarter worth $210,000. McGowan Group Asset Management Inc. boosted its stake in shares of UnitedHealth Group by 8.9% in the 1st quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock valued at $379,000 after purchasing an additional 61 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. raised its stake in UnitedHealth Group by 31.8% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock worth $127,592,000 after buying an additional 60,300 shares during the last quarter. MAS Advisors LLC grew its holdings in UnitedHealth Group by 10.8% during the 1st quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock worth $241,000 after acquiring an additional 45 shares during the period. Finally, First Western Trust Bank acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at about $875,000. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. Oppenheimer reissued an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Royal Bank of Canada restated an “outperform” rating and issued a $596.00 price target on shares of UnitedHealth Group in a report on Thursday, February 29th. Stephens reissued an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 8th. Bank of America reiterated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Finally, Barclays assumed coverage on UnitedHealth Group in a report on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $579.33.

View Our Latest Research Report on UnitedHealth Group

Insider Buying and Selling at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded down $31.54 during midday trading on Tuesday, reaching $458.16. The stock had a trading volume of 11,864,558 shares, compared to its average volume of 4,202,450. The firm has a market capitalization of $422.39 billion, a PE ratio of 19.08, a P/E/G ratio of 1.35 and a beta of 0.54. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. The firm’s 50-day moving average price is $502.03 and its 200 day moving average price is $519.13. UnitedHealth Group Incorporated has a 12 month low of $445.68 and a 12 month high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The business had revenue of $94.43 billion during the quarter, compared to analyst estimates of $92.13 billion. During the same period in the previous year, the business earned $5.34 EPS. UnitedHealth Group’s revenue was up 14.1% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.64%. UnitedHealth Group’s dividend payout ratio is currently 31.54%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.